デフォルト表紙
市場調査レポート
商品コード
1260005

先進創傷治療の世界市場:市場規模、シェア、成長分析、製品タイプ別(被覆材(フォーム、ハイドロコロイド))、創傷タイプ別(手術創、外傷)、エンドユーザー別(病院、在宅医療)-業界予測(2022年~2028年)

Global Advanced Wound Care Market Size, Share, Growth Analysis, By Product(Dressings (Foam, Hydrocolloid), By Wound Type(Surgical, Traumatic), By End-User(Hospital, Homecare) - Industry Forecast 2022-2028

出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
先進創傷治療の世界市場:市場規模、シェア、成長分析、製品タイプ別(被覆材(フォーム、ハイドロコロイド))、創傷タイプ別(手術創、外傷)、エンドユーザー別(病院、在宅医療)-業界予測(2022年~2028年)
出版日: 2022年11月25日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の先進創傷治療の市場規模は、2021年の65億米ドルから、2027年には168億米ドルになると予測されており、2020年から2027年までの予測期間中のCAGRは5.3%となっています。人口動態の変化や、金額に応じたサービスに対する嗜好の高まり、政府の支援は、市場の成長を促進しています。

当レポートでは、世界の先進創傷治療市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

エグゼクティブサマリー

親市場分析

市場概要

市場規模

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • SWOT分析

主要な市場の洞察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品分析
  • マクロ経済指標

市場力学と展望

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制状況
  • SWOT分析
  • ポーター分析
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力
    • 政治的影響
    • 経済的影響
    • 社会的影響
    • 技術的影響
    • 環境的影響
    • 法的影響

世界の先進創傷治療市場:製品別

  • 市場概要
  • 被覆材(フォーム、ハイドロコロイド、フィルム、アルギン酸)
  • NPWT
  • デブリードマン装置
  • 移植片・基質
  • 局所薬

世界の先進創傷治療市場:創傷タイプ別

  • 市場概要
  • 手術創
  • 外傷
  • 潰瘍
  • 火傷

世界の先進創傷治療市場:エンドユーザー別

  • 市場概要
  • 病院
  • 在宅医療

世界の先進創傷治療市場規模:地域別

  • 市場概要
  • 北米
  • 米国
  • カナダ
  • 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
  • ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
  • 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情勢

  • 主要5社の比較
  • 主要企業の市場ポジショニング(2021年)
  • 主要な市場参入企業が採用した戦略
  • 主要成功戦略
  • 開発別
  • 企業別
  • 年別
  • 市場における最近の活動
  • 主要企業の市場シェア(%)(2021年)

主な企業プロファイル

  • 3M Company(米国)
  • Smith & Nephewplc(英国)
  • ConvaTec Group Plc(英国)
  • Coloplast A/S(デンマーク)
  • Molnlycke Health Care AB(スウェーデン)
  • Integra LifeSciences Holdings Corporation(米国)
  • PAUL HARTMANN AG(ドイツ)
  • B. Braun Melsungen AG(ドイツ)
  • Cardinal Health Inc.(米国)
  • Organogenesis Holdings Inc.(米国)
目次
Product Code: SQMIG35D2009

Advanced Wound Care Market was valued at USD 16,800 Million by 2027 from USD 6,500 Million in 2021, at a CAGR of 5.3% during the forecast period (2020-2027).

Acute and chronic diseases are treated with advanced wound care products. Traditional wound care products and solutions are being phased out in favour of advanced wound care products that provide immediate and effective treatment. Slivers and alginates are used in wound dressings for chronic injuries and surgeries to keep the wound from becoming infected. Furthermore, biomaterials and skin grafts are used to treat wounds that cannot heal on their own. As a result, the market is seeing an increase in new and more advanced products, which is likely to aid market growth.

The changing demographics of the market, as well as the rising preference for value-based services, will drive market growth. The ageing population has a higher demand for at-home health services, which increases the demand for healthcare providers. Government support is another factor that influences market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of Asia Pacific Advanced Wound Care Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global advanced wound care market is segmented by Product (Dressings (Foam, Hydrocolloid, Film, Alginate), NPWT, Debridement Devices, Grafts, Matrices, Topical Agents), By Wound Type (Surgical, Traumatic, Ulcers, Burns), By End User (Hospital, Homecare) &. Based on region Advanced Wound Care Market is categorized into: North America, Europe, Asia-Pacific, South America, and MEA.

Driver

Traumatic wounds, the global geriatric population, the rising number of surgeries, and rising cases of diabetes and obesity are driving the global advanced wound care market. Diabetes and obesity play an important role in the development of wound complexity, increasing global demand for advanced wound care.

As technology advances, the market sees new product innovations. Smart innovations include smart wound dressings with built-in sensors that emit light or glow when an infection begins to develop. This and other such innovations have been the subject of research. Aside from this, there are several other more effective and efficient product innovations on the market. Convatec, for example, introduced Foam Lite in April 2017, a light, flexible silicone foam dressing for managing low to non-exuding chronic and acute wounds. As a result, such factors are likely to have a positive impact on market growth during the forecast period.

Restraint

The high cost of treating chronic wounds is one of the key restraining factors identified for this market, which has a significant impact on the adoption of wound care solutions. Delayed diagnosis in emerging markets such as China, Brazil, and India, which raises treatment costs, may also lead to low consumer acceptance.

Market Trends

Bioactive therapies are used to treat advanced wounds and will drive market growth. To meet the growing demand for urgent and effective wound management, key market players are employing nanofiber, allograft, xenograft, and cell-based therapies. The advantages of bioactive therapies, such as reduced treatment time and wound cost, are gaining popularity among consumers.

Increased funding and investment in market research and development is another trend driving positive market growth. Leading players in the advanced wound care market are heavily investing in research and development. These R&D activities are geared towards the creation of technologically advanced products. High R&D activity in the industry will result in the development of superior wound care products.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Advanced Wound Care Market by Product
  • Market Overview
  • Dressings (Foam
  • Hydrocolloid
  • Film
  • Alginate)
  • NPWT
  • Debridement Devices
  • Grafts
  • Matrices
  • Topical Agents)
  • Global Advanced Wound Care Market by Wound Type
  • Market Overview
  • Surgical
  • Traumatic
  • Ulcers
  • Burns
  • Global Advanced Wound Care Market by End-User
  • Market Overview
  • Hospital
  • Homecare
  • Global Advanced Wound Care Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • 3M Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Smith & Nephewplc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • ConvaTec Group Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Molnlycke Health Care AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Integra LifeSciences Holdings Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • PAUL HARTMANN AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Cardinal Health Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Organogenesis Holdings Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments